New Human Insulin Analog Approved

The FDA hasapproved another formulation of insulin lispro —a type of rapid-acting human insulin analog—to improve glycemic control in adults and children aged 3 years or older with type 1 diabetes and in adults with type 2 diabetes. Marketed as Admelog, the product is a follow-on drug approved through an abbreviated pathway that relied in part on its s imilarity to Humalog, an insulin lispro approved in1996.
Source: JAMA - Category: General Medicine Source Type: research